DOUGLAS A. ARENBERG, M.D.
Associate Professor of Internal Medicine

Education and Training: M.D., University of Illinois, Chicago, IL
Clinical Research and Training: Residency, Internal Medicine, University of Michigan, Ann Arbor, MI
Fellowship: Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI
Major Clinical Interests: Lung cancer (diagnosis and managing complications), drug induced & occupational lung disease, critical care
Major Research Interests: Angiogenesis, the role of chemokines and migration inhibitory factor (MIF) in cancer, pulmonary fibrosis
  • White EW, Strom SR, Wys NB, and Arenberg DA.  Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity.  Journal of Immunology. 2001 166(12) 7549-7555.
  • White EW, Strieter RM, and Arenberg DA.  Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer.  Current Medicinal Chemistry-Anticancer Agents, May 2002, 2(3) 403-417.
  • Arenberg DA, and Bucala R. Macrophage Migration Inhibitory Factor (MIF) In the Cytokine Handbook, 4th Edition.  Eds. A. Thomson and M. Lotze.
    Academic Press. London, UK.
  • White ES, Flaherty KR, Carskadon S, Brant A., Iannettoni MD, Yee J, Orringer MB, and Arenberg, DA. Macrophage migration inhibitory factor
    (MIF) and CXC chemokine expression in human non-small cell lung cancer (NSCLC): Role in Angiogenesis and Prognosis. Clin Can Res.  2003 9(2) 853-860
  • White ES, Carskadon SL, Dickey EG, Livant DL, Markwart S, and Arenberg DA. Integrin ?4?1 regulates basement membrane invasion by fibrotic-lung
    fibroblasts: A role for PTEN.  Am J Resp Crit Care Med, (In Press 2003).

Return to the Listing of Pulmonary Faculty
Return to the Pulmonary Division Homepage